Xiaowen C. Tang - Publications

Multicenter Analysis of Transplant Outcomes for the Newly Defined MDS/AML Entity in the 2022 ICC: Risk Stratification and Comparison with AML.

Journal: Transplantation and cellular therapy

Published: January 23, 2026

Quantitative evaluation of T-cell repertoire restoration following hematopoietic stem cell transplantation in patients with and without graft versus host disease.

Journal: Frontiers in immunology

Published: December 30, 2025

BiRD Regimen Followed by Anti-BCMA CAR-T Cell Immunotherapy as First-Line Therapy for Newly Diagnosed Multiple Myeloma: A Prospective, Single-Arm, Phase 2 Trial.

Journal: American journal of hematology

Published: December 27, 2025

Efficacy of Low-Dose Rituximab as Preemptive Treatment of EBV DNA-emia After Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: December 06, 2025

A lower-intensity, venetoclax-containing protocol is effective in adults with newly diagnosed mixedphenotype acute leukemia.

Journal: Haematologica

Published: November 03, 2025

Integrated Radiomics-Enhanced machine learning models for accurate diagnosis and prediction of oGVHD-Related ocular complications.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: September 22, 2025

Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter study.

Journal: Annals of hematology

Published: August 12, 2025

Expert Consensus on Cytomegalovirus Management in Recipients of CAR-T Cell and Bispecific Antibody Therapies.

Journal: Journal of evidence-based medicine

Published: August 11, 2025

Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter study.

Journal: Haematologica

Published: July 07, 2025

Identification of rare recurrent FNBP1::JAK2 fusion in myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions.

Journal: Leukemia & lymphoma

Published: March 31, 2025

Real-world Efficacy and Safety of Flumatinib as the First-line Treatment in Patients With de novo Philadelphia-positive Acute Lymphoblastic Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 17, 2025

Effect of sorafenib on prognosis in patients with low-allelic-ratio FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation.

Journal: Leukemia research

Published: February 27, 2025